Highlights of the programme include:
- Advances in cancer screening, diagnostics and treatment, including vaccines, immunotherapy, artificial intelligence and precision medicine
- Abstract-led sessions showcasing implementation science
- Tobacco control – countering industry influence, regulating new products such as e-cigarettes, discussions on the “generational ban” implemented notably in New Zealand
- The threat of antimicrobial resistance for cancer patients, the need for infection control and the rational use of drugs
- The right to assisted dying – approaches and cultural contexts
- Improving access to cancer medicines in low-income regions
- The impact of COVID-19
- Advances in Universal Health Coverage and cancer control
- Hearing from people living with cancer – breaking the taboo around cancer and sexuality
Please note that registration or accreditation is only required to access the Congress (but not the press conference).
Wednesday 19 October 2022 – 10:00-10:40 AM Central European Time (Find your time here)
- Onsite: International Conference Center Geneva. (Watch the recording above)
- Online: Zoom webinar. (Watch the recording above)
The press conference will touch upon advances in cancer prevention and care, the rise of non-communicable diseases (NCDs) in sub-Saharan Africa and how NCD-related mortality is expected to surpass deaths due to communicable diseases, as well as the patient perspective and how patient advocacy can improve the lives of people living with cancer. The conference will also feature the release by the International Agency for Research on Cancer (IARC) of inaugural global data on maternal cancer orphans (preliminary findings).
- Cary Adams, CEO, Union for International Cancer Control (UICC), Switzerland
- Bente Mikkelsen, Director of Non-Communicable Diseases, World Health Organization WHO, Switzerland
- Alejandra de Cima Aldrete, Founder and President of Fundación CIMA, survivor and patient advocate, Mexico
- Valerie McCormack, Deputy Branch Head Environment and Lifestyle Epidemiology, International Agency for Research on Cancer (IARC), France
- Miriam Mutebi, UICC Board Member, Consultant Breast Surgical Oncologist, Clinical epidemiologist & health systems researcher, Aga Khan University Hospital, Kenya
- Olivier Michielin, Chairman of the Department of Oncology, Geneva University Hospitals, Switzerland
Application for accreditation to the Congress is open to all media professionals working for newspapers, news services, magazines, radio and television stations, and online publications engaged in disseminating news.
Media registration is free for accredited press and includes all privileges of a full participant.
Media registration is limited to accredited journalists and only media badge holders will be admitted access on-site. Publishers and representatives of sales, advertising or marketing departments of publications or other news organisations may not register as media.
APPLYING FOR ACCREDITATION
Applicants for media accreditation should submit an application with supporting documents, including:
- Press credentials and/or business card
- Published news outlet / freelance materials
The UICC Press & Media Team will send confirmation and registration instructions once your supporting documents are approved.
Press and media:
- Eric Grant: +41 79 1241523, firstname.lastname@example.org
- Michael Kessler: +34 655 79 26 99 - email@example.com
- Nicole Engelbrecht: +41 79 547 0822- firstname.lastname@example.org
- Ronan Carella email@example.com
Important information: You will not be able to register as a media representative to the 2022 World Cancer Congress until your accreditation has been approved by the UICC Press & Media Team. Note that their decision regarding all press registration requests are final.